DOCSLIB.ORG

Biosynthetic Gene Clusters Guide Antibiotic Discovery

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Biosynthetic Gene Clusters Guide Antibiotic Discovery BIOSYNTHETIC GENE CLUSTERS GUIDE ANTIBIOTIC DISCOVERY PhD Thesis – E.J. Culp - McMaster University – Biochemistry and Biomedical Sciences BIOSYNTHETIC GENE CLUSTERS GUIDE RATIONAL ANTIBIOTIC DISCOVERY FROM ACTINOMYCETES By ELIZABETH J. CULP, B.Sc. A thesis submitted to the School of Graduate Studies in partial fulfillment of the requirements for the degree of Doctor of Philosophy McMaster University © Copyright Elizabeth Jane Culp, October 2020 i PhD Thesis – E.J. Culp - McMaster University – Biochemistry and Biomedical Sciences DESCRIPTIVE NOTE McMaster University DOCTOR OF PHILOSOPHY (2020) Hamilton, Ontario (Biochemistry and Biomedical Sciences) TITLE: Biosynthetic gene clusters guide rational antibiotic discovery from Actinomycetes AUTHOR: Elizabeth J. Culp, B.Sc. SUPERVISOR: Gerard D. Wright, Ph.D. NUMBER OF PAGES: xv; 231 ii PhD Thesis – E.J. Culp - McMaster University – Biochemistry and Biomedical Sciences Foreword LAY ABSTRACT Antibiotics are essential for treating life-threatening infections, but the rise of antibiotic resistance renders them ineffective. To treat these drug-resistant infections, new antibiotics that work in new ways are required. A family of bacteria commonly isolated from soil called Actinomycetes produce most antibiotics we use today, but it has become increasingly difficult to find new antibiotics from this source. My work describes three techniques that can be applied to actinomycetes to help overcome the challenges associated with antibiotic discovery. Specifically, these techniques guide discovery efforts by making use of regions in actinomycete genomes called biosynthetic gene clusters that often encode antibiotics. In doing so, I describe ways to uncover rare antibiotics from actinomycete strains that produce common and uninteresting antibiotics, use antibiotic family trees to discover antibiotics that work in new ways, and apply antibiotic resistance to identify biosynthetic gene clusters likely to act on a certain bacterial target. iii PhD Thesis – E.J. Culp - McMaster University – Biochemistry and Biomedical Sciences ABSTRACT As the spread of antibiotic resistance threatens our ability to treat infections, avoiding the return of a pre-antibiotic era urgently requires the discovery of novel antibiotics. Actinomycetes, a family of bacteria commonly isolated from soil, are a proven source of clinically useful antibiotics. However, easily identifiable metabolites have been exhausted and the rediscovery of common antibiotics thwarts searches for rarer molecules. Sequencing of actinomycete genomes reveals that they contain far more biosynthetic gene clusters with the potential to encode antibiotics than whose products can be readily observed in the laboratory. The work presented in this thesis revolves around developing approaches to mine these previously inaccessible metabolites as a source of new antibiotics. First, I describe how inactivation of biosynthetic gene clusters for common antibiotics can uncover rare antibiotics otherwise masked in these strains. By applying CRISPR-Cas9 to knockout genes encoding nuisance antibiotics, I develop a simple strategy to reveal the hidden biosynthetic potential of actinomycete strains that can be used to discover rare or novel antibiotics. Second, I describe the use of the evolutionary history of biosynthetic gene clusters to prioritize divergent members of an antibiotic family, the glycopeptide antibiotics, that are likely to possess new biological activities. Using these predictions, I uncover a novel functional class of glycopeptide antibiotics that blocks the action of autolysins, essential peptidoglycan hydrolases required for remodelling the cell wall during growth. Finally, I apply target-directed genome mining, which makes use of target duplication as a predicted resistance mechanism within an antibiotic’s biosynthetic gene cluster. Using this approach, I discover the association of a family of gene clusters with the housekeeping protease ClpP and characterize the produced metabolite’s effect on ClpP function. These three research projects mine previously inaccessible chemical matter from a proven source of antibiotics, actinomycetes. The techniques and antibiotics described are required now more than ever to develop life-saving antibiotics capable of combatting multidrug-resistant pathogens. iv PhD Thesis – E.J. Culp - McMaster University – Biochemistry and Biomedical Sciences ACKNOWLEDGEMENTS To Gerry – I can’t thank you enough for the opportunities, support and advice you’ve provided. Your encouragement and excitement through the hills and valleys of science always kept me going. Your dedication to excellence inspires the type of scientist I want to be, and your belief in and motivation of your students is the type of mentor I will model myself after. To Marie and Brian, my committee members – thank you for making my committee meetings productive and motivational, and taking the time for thoughtful contemplation and helpful suggestions about my science. To the Wright lab members, past and present – I have you to thank for everything in this thesis, but also for making the journey so much fun. Thank you all. Especially, and in no particular order…Nick – most of my projects wouldn’t exist without your insight and work. Wen – thank you for teaching me everything I know about natural product purification, purifying countless compounds for me, and also endless unsolicited advice about real estate. Min – I trust no one more than you for advice about Streptomyces. I owe you many favours. Mike – I’ll miss our walks to get coffee; a lot of great science ideas came from those. Also a lot of puns. Linda – Thank you for keeping the lab together, from teaching us the ropes to running things smoothly. Kalinka – thanks for everything you do for the lab and being my early morning buddy. Grace – my CRISPR partner in crime. Thanks for spearheading that project, and also for imparting the way you say “OK” and “Oh boy” onto me. Dave – your enthusiasm for science is infectious. Thanks for all the helpful discussions and always having a willingness to lend expertise. Allison, Drew, Haley, Matt, Adam, Caitlyn, Andy, Christian, Emily, Vishwas – you guys are such great friends and made it all a blast. Thanks for all the ridiculous shenanigans. To my spin crew – Thanks for the sweat puddles, heavy beats, and always giving me somewhere to retreat to. To my awesome family – Thanks for listening to my complaints, fixing my broken stuff and 9+ years of visiting me in Hamilton. I could not have done this without your endless love and support. To so many others who made this work possible – Every time I thought I was finished writing this acknowledgments section I thought of more people who helped me along the way. Thank you. v PhD Thesis – E.J. Culp - McMaster University – Biochemistry and Biomedical Sciences Table of Contents Foreword ........................................................................................................................... iii Lay Abstract ................................................................................................................... iii Abstract ........................................................................................................................... iv Acknowledgements .......................................................................................................... v List of figures .................................................................................................................. ix List of tables ................................................................................................................. xiii List of abbreviations...................................................................................................... xiv Declaration of Academic Achievement ......................................................................... xv Chapter I – Introduction ................................................................................................... 1 Natural products as a source of antibiotics ...................................................................... 2 Biosynthetic gene clusters ................................................................................................ 3 Key natural product classes ......................................................................................... 5 Barriers to discovery: dereplication ................................................................................. 7 Easing the dereplication burden ................................................................................... 7 Exploring unchartered territory for new NPs ............................................................... 9 Barriers to discovery: Cryptic biosynthetic gene clusters .............................................. 11 Pleiotropic approaches to BGC activation ................................................................. 11 Targeted approaches to BGC activation .................................................................... 14 Purpose and goals of this thesis ..................................................................................... 20 Chapter II – Hidden antibiotics in actinomycetes can be identified by inactivation of gene clusters for common antibiotics ............................................................................. 21 Preface ............................................................................................................................ 22 Abstract .........................................................................................................................
Load more

Recommended publications
  • Natural Thiopeptides As a Privileged Scaffold for Drug Discovery and Therapeutic Development
    – MEDICINAL Medicinal Chemistry Research (2019) 28:1063 1098 CHEMISTRY https://doi.org/10.1007/s00044-019-02361-1 RESEARCH REVIEW ARTICLE Natural thiopeptides as a privileged scaffold for drug discovery and therapeutic development 1 1 1 1 1 Xiaoqi Shen ● Muhammad Mustafa ● Yanyang Chen ● Yingying Cao ● Jiangtao Gao Received: 6 November 2018 / Accepted: 16 May 2019 / Published online: 29 May 2019 © Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract Since the start of the 21st century, antibiotic drug discovery and development from natural products has experienced a certain renaissance. Currently, basic scientific research in chemistry and biology of natural products has finally borne fruit for natural product-derived antibiotics drug discovery. A batch of new antibiotic scaffolds were approved for commercial use, including oxazolidinones (linezolid, 2000), lipopeptides (daptomycin, 2003), and mutilins (retapamulin, 2007). Here, we reviewed the thiazolyl peptides (thiopeptides), an ever-expanding family of antibiotics produced by Gram-positive bacteria that have attracted the interest of many research groups thanks to their novel chemical structures and outstanding biological profiles. All members of this family of natural products share their central azole substituted nitrogen-containing six-membered ring and are fi 1234567890();,: 1234567890();,: classi ed into different series. Most of the thiopeptides show nanomolar potencies for a variety of Gram-positive bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and penicillin-resistant Streptococcus pneumonia (PRSP). They also show other interesting properties such as antiplasmodial and anticancer activities. The chemistry and biology of thiopeptides has gathered the attention of many research groups, who have carried out many efforts towards the study of their structure, biological function, and biosynthetic origin.
    [Show full text]
  • Autogenous Transcriptional Activation of a Thiostrepton- Induced Gene in Streptomyces Lividans
    The EMBO Journal vol.12 no.8 pp.3183-3191, 1993 Autogenous transcriptional activation of a thiostrepton- induced gene in Streptomyces lividans David J.Holmes1, Jose L.Caso2 synthesis is irreversibly blocked (Cundliffe, 1971). Although and Charles J.Thompson3 it can be demonstrated in vitro that thiostrepton binds specifically to a region of base pairing extending for 58 Institut Pasteur, 28 rue du Docteur Roux, 75015 Paris, France nucleotides in the ribosomal RNA (Ryan et al., 1991; 'Present address: SmithKlineBeecham Pharmaceuticals, Departamento Thompson and Cundliffe, 1991) but not to ribosomal de Biotecnologfa, C/Santiago Grisolia s/n, Tres Cantos (Madrid), Spain proteins, both components are thought to play a role in 2Present address: Universidad de Oviedo, Facultad de Medicina, forming a stable drug -ribosome complex. Resistance to the Departamento de Biologfa Funcional, Area de Microbiologfa, c/Julian antibiotic in S.azureus is conferred by the action of a Claverfa, s/n, 33006-Oviedo, Spain methylase which modifies a specific nucleotide within this 3Present address: Biozentrum, der Universitit Basel, Department of Microbiology, Klingelbergstrasse 70, CH-4056 Basel, Switzerland sequence (Cundliffe, 1978; Thompson et al., 1982a). The gene encoding the methylase, tsr, has been incorporated into Communicated by H.Buc most streptomycete cloning vectors including p1161 (Thompson et al., 1982b) used in this study (Hopwood et al., known as an Although the antibiotic thiostrepton is best 1985) and is widely used as the primary selectable marker. inhibitor of protein synthesis, it also, at extremely low Ribosomes isolated from S. azureus or S. lividans containing concentrations (< 10-9 M), induces the expression of a in Streptomyces the cloned tsr gene do not detectably bind thiostrepton regulon of unknown function certain (Thompson et al., 1982a).
    [Show full text]
  • Thiocillin and Micrococcin Exploit the Ferrioxamine Receptor of Pseudomonas Aeruginosa for Uptake
    bioRxiv preprint doi: https://doi.org/10.1101/2020.04.23.057471; this version posted April 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 Thiocillin and Micrococcin Exploit the Ferrioxamine Receptor of Pseudomonas aeruginosa for Uptake 2 Derek C. K. Chan and Lori L. Burrows* 3 Michael G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and 4 Biomedical Sciences, McMaster University, 1200 Main Street West, Hamilton, Ontario L8N 3Z5, Canada 5 KEYWORDS: drug discovery, mechanism of uptake, thiopeptide, antimicrobial activity, siderophore, trojan 6 horse, 7 ABSTRACT 8 Thiopeptides are a class of Gram-positive antibiotics that inhibit protein synthesis. They have been 9 underutilized as therapeutics due to solubility issues, poor bioavailability, and lack of activity against 10 Gram-negative pathogens. We discovered recently that a member of this family, thiostrepton, has activity 11 against Pseudomonas aeruginosa and Acinetobacter baumannii under iron-limiting conditions. 12 Thiostrepton uses pyoverdine siderophore receptors to cross the outer membrane, and combining 13 thiostrepton with an iron chelator yielded remarkable synergy, significantly reducing the minimal 14 inhibitory concentration. These results led to the hypothesis that other thiopeptides could also inhibit 15 growth by using siderophore receptors to gain access to the cell. Here, we screened six thiopeptides for 16 synergy with the iron chelator deferasirox against P. aeruginosa and a mutant lacking the pyoverdine 17 receptors FpvA and FpvB.
    [Show full text]
  • Diversity of Free-Living Nitrogen Fixing Bacteria in the Badlands of South Dakota Bibha Dahal South Dakota State University
    South Dakota State University Open PRAIRIE: Open Public Research Access Institutional Repository and Information Exchange Theses and Dissertations 2016 Diversity of Free-living Nitrogen Fixing Bacteria in the Badlands of South Dakota Bibha Dahal South Dakota State University Follow this and additional works at: http://openprairie.sdstate.edu/etd Part of the Bacteriology Commons, and the Environmental Microbiology and Microbial Ecology Commons Recommended Citation Dahal, Bibha, "Diversity of Free-living Nitrogen Fixing Bacteria in the Badlands of South Dakota" (2016). Theses and Dissertations. 688. http://openprairie.sdstate.edu/etd/688 This Thesis - Open Access is brought to you for free and open access by Open PRAIRIE: Open Public Research Access Institutional Repository and Information Exchange. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of Open PRAIRIE: Open Public Research Access Institutional Repository and Information Exchange. For more information, please contact [email protected]. DIVERSITY OF FREE-LIVING NITROGEN FIXING BACTERIA IN THE BADLANDS OF SOUTH DAKOTA BY BIBHA DAHAL A thesis submitted in partial fulfillment of the requirements for the Master of Science Major in Biological Sciences Specialization in Microbiology South Dakota State University 2016 iii ACKNOWLEDGEMENTS “Always aim for the moon, even if you miss, you’ll land among the stars”.- W. Clement Stone I would like to express my profuse gratitude and heartfelt appreciation to my advisor Dr. Volker Brӧzel for providing me a rewarding place to foster my career as a scientist. I am thankful for his implicit encouragement, guidance, and support throughout my research. This research would not be successful without his guidance and inspiration.
    [Show full text]
  • Investigations of the Natural Product Antibiotic
    INVESTIGATIONS OF THE NATURAL PRODUCT ANTIBIOTIC THIOSTREPTON FROM STREPTOMYCES AZUREUS AND ASSOCIATED MECHANISMS OF RESISTANCE by Cullen Lucan Myers A thesis presented to the University of Waterloo in fulfillment of the thesis requirement for the degree of Doctor of Philosophy in Chemistry Waterloo, Ontario, Canada, 2013 © Cullen Lucan Myers 2013 AUTHOR’S DECLARATION I hereby declare that I am the sole author of this thesis. This is a true copy of the thesis, including any required final revisions, as accepted by my examiners. I understand that my thesis may be made electronically available to the public. ii ABSTRACT The persistence and propagation of bacterial antibiotic resistance presents significant challenges to the treatment of drug resistant bacteria with current antimicrobial chemotherapies, while a dearth in replacements for these drugs persists. The thiopeptide family of antibiotics may represent a potential source for new drugs and thiostrepton, the prototypical member of this antibiotic class, is the primary subject under study in this thesis. Using a facile semi-synthetic approach novel, regioselectively-modified thiostrepton derivatives with improved aqueous solubility were prepared. In vivo assessments found these derivatives to retain significant antibacterial ability which was determined by cell free assays to be due to the inhibition of protein synthesis. Moreover, structure-function studies for these derivatives highlighted structural elements of the thiostrepton molecule that are important for antibacterial activity. Organisms that produce thiostrepton become insensitive to the antibiotic by producing a resistance enzyme that transfers a methyl group from the co- factor S-adenosyl-L-methionine (AdoMet) to an adenosine residue at the thiostrepton binding site on 23S rRNA, thus preventing binding of the antibiotic.
    [Show full text]
  • Investigating the Relationship Between Amphotericin B and Extracellular
    Investigating the relationship between amphotericin B and extracellular vesicles produced by Streptomyces nodosus By Samuel John King A thesis submitted in partial fulfilment of the requirements for the degree of Master of Research School of Science and Health Western Sydney University 2017 Acknowledgements A big thank you to the following people who have helped me throughout this project: Jo, for all of your support over the last two years; Ric, Tim, Shamilla and Sue for assistance with electron microscope operation; Renee for guidance with phylogenetics; Greg, Herbert and Adam for technical support; and Mum, you're the real MVP. I acknowledge the services of AGRF for sequencing of 16S rDNA products of Streptomyces "purple". Statement of Authentication The work presented in this thesis is, to the best of my knowledge and belief, original except as acknowledged in the text. I hereby declare that I have not submitted this material, either in full or in part, for a degree at this or any other institution. ……………………………………………………..… (Signature) Contents List of Tables............................................................................................................... iv List of Figures .............................................................................................................. v Abbreviations .............................................................................................................. vi Abstract .....................................................................................................................
    [Show full text]
  • Biosynthesis of the Acetyl-Coa Carboxylase-Inhibiting Antibiotic, Andrimid, in Serratia Is Regulated by Hfq and The
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Apollo 1 Biosynthesis of the acetyl-CoA carboxylase-inhibiting 2 antibiotic, andrimid, in Serratia is regulated by Hfq and the 3 LysR-type transcriptional regulator, AdmX. 4 Miguel A. Matillaab*, Veronika Nogellovaa, Bertrand Morelb, Tino Krellb and 5 George P.C. Salmonda* 6 7 aDepartment of Biochemistry, University of Cambridge, Tennis Court Road, 8 Cambridge, UK, CB2 1QW. 9 bDepartment of Environmental Protection, Estación Experimental del Zaidín, 10 Consejo Superior de Investigaciones Científicas, Prof. Albareda 1, Granada, 11 Spain, 18008 12 13 Running title: Regulation of andrimid biosynthesis 14 15 *Address correspondence to George P.C. Salmond, Department of 16 Biochemistry, University of Cambridge, Tennis Court Road, Cambridge, UK, 17 CB2 1QW. Tel: +44 (0)1223 333650; Fax: +44 (0)1223 766108; E-mail: 18 [email protected] *Address correspondence to Miguel A. Matilla, Department of Environmental Protection, Estación Experimental del Zaidín, Consejo Superior de Investigaciones Científicas, Prof. Albareda 1, Granada, Spain, 18008. Tel: +34 958 181600; Fax: + 34 958 135740; E-mail: [email protected] 1 1 SUMMARY 2 Infections due to multidrug-resistant bacteria represent a major global health challenge. 3 To combat this problem, new antibiotics are urgently needed and some plant- 4 associated bacteria are a promising source. The rhizobacterium Serratia plymuthica 5 A153 produces several bioactive secondary metabolites, including the anti-oomycete 6 and antifungal haterumalide, oocydin A, and the broad spectrum polyamine antibiotic, 7 zeamine. In this study, we show that A153 produces a second broad spectrum 8 antibiotic, andrimid.
    [Show full text]
  • Towards a New Science of Secondary Metabolism
    The Journal of Antibiotics (2013) 66, 387–400 & 2013 Japan Antibiotics Research Association All rights reserved 0021-8820/13 www.nature.com/ja REVIEW ARTICLE Towards a new science of secondary metabolism Arryn Craney, Salman Ahmed and Justin Nodwell Secondary metabolites are a reliable and very important source of medicinal compounds. While these molecules have been mined extensively, genome sequencing has suggested that there is a great deal of chemical diversity and bioactivity that remains to be discovered and characterized. A central challenge to the field is that many of the novel or poorly understood molecules are expressed at low levels in the laboratory—such molecules are often described as the ‘cryptic’ secondary metabolites. In this review, we will discuss evidence that research in this field has provided us with sufficient knowledge and tools to express and purify any secondary metabolite of interest. We will describe ‘unselective’ strategies that bring about global changes in secondary metabolite output as well as ‘selective’ strategies where a specific biosynthetic gene cluster of interest is manipulated to enhance the yield of a single product. The Journal of Antibiotics (2013) 66, 387–400; doi:10.1038/ja.2013.25; published online 24 April 2013 Keywords: actinomycetes; cryptic gene clusters; natural products; regulation; secondary metabolism; strain improvement; streptomyces INTRODUCTION novel compounds or compounds of medicinal utility; however, Secondary metabolites are biologically active small molecules that are these ‘cryptic’ pathways have generated considerable interest as they not required for viability but which provide a competitive advantage represent an enormous reservoir of new chemical matter and may to the producing organism.
    [Show full text]
  • A Novel Approach to the Discovery of Natural Products from Actinobacteria Rahmy Tawfik University of South Florida, [email protected]
    University of South Florida Scholar Commons Graduate Theses and Dissertations Graduate School 3-24-2017 A Novel Approach to the Discovery of Natural Products From Actinobacteria Rahmy Tawfik University of South Florida, [email protected] Follow this and additional works at: http://scholarcommons.usf.edu/etd Part of the Microbiology Commons Scholar Commons Citation Tawfik, Rahmy, "A Novel Approach to the Discovery of Natural Products From Actinobacteria" (2017). Graduate Theses and Dissertations. http://scholarcommons.usf.edu/etd/6766 This Thesis is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact [email protected]. A Novel Approach to the Discovery of Natural Products From Actinobacteria by Rahmy Tawfik A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science Department of Cell Biology, Microbiology & Molecular Biology College of Arts and Sciences University of South Florida Major Professor: Lindsey N. Shaw, Ph.D. Edward Turos, Ph.D. Bill J. Baker, Ph.D. Date of Approval: March 22, 2017 Keywords: Secondary Metabolism, Soil, HPLC, Mass Spectrometry, Antibiotic Copyright © 2017, Rahmy Tawfik Acknowledgements I would like to express my gratitude to the people who have helped and supported me throughout this degree for both scientific and personal. First, I would like to thank my mentor and advisor, Dr. Lindsey Shaw. Although my academics were lacking prior to entering graduate school, you were willing to look beyond my shortcomings and focus on my strengths.
    [Show full text]
  • JMBFS / Surname of Author Et Al. 20Xx X (X) X-Xx
    NOVEL ACTINOBACTERIAL DIVERSITY IN KAZAKHSTAN DESERTS SOILS AS A SOURCE OF NEW DRUG LEADS Arailym Ziyat*1, Professor Michael Goddfellow2, Ayaulym Nurgozhina1, Shynggys Sergazy1, Madiyar Nurgaziev1 Address(es): Arailym Ziyat, 1PI “National Laboratory Astana”, Centre for Life Sciences, Laboratory of Human Microbiome and Longevity, Kabanbay Batyr Ave. 53, 010000, Astana, Republic of Kazakhstan. 2Newcastle University, Faculty of Science, Agriculture & Engineering, School of Biology, NE1 7RU, Newcastle University, United Kingdom. *Corresponding author: [email protected] doi: 10.15414/jmbfs.2019.8.4.1057-1065 ARTICLE INFO ABSTRACT Received 24. 10. 2018 Discovering new metabolites, notably antibiotics, by isolation and screening novel actinomycetes from extreme habitats gave extraordinary results that can be adapted in the future for healthcare. However, it was little attention payed to desert soils in Central Revised 13. 11. 2018 Asia, such as from Kazakhstan. Accepted 13. 11. 2018 Taxonomic approach was to isolate selectively, dereplicate and classify actinomycetes from two Kazakhstan Deserts (Betpakdala and Published 1. 2. 2019 Usturt Plateu). The most representative isolates from colour-groups were describe via 16S rRNA gene sequence analysis. Relatively large number, of strains from environmental soil samples were classified into Streptomyces genera. Moreover, three strains Regular article from two different soil samples were identified as relatively close to Pseudonocarida genera. All representative isolates were screened for bioactive compound against wild type microorganisms, as a result, of it can be interpreted that approximately half of screened strains are likely to produce metabolites which inhibits cell growth. The results of this project demonstrate for the first time that arid regions of Kazakhstan soils are rich reservoirs of cultivable novel actinobacteria with the capacity to produce bioactive compounds that can be developed as drug leads for medicine.
    [Show full text]
  • IJMICRO.2020.8816111.Pdf
    University of Calgary PRISM: University of Calgary's Digital Repository Libraries & Cultural Resources Open Access Publications 2020-11-24 Molecular-Based Identification of Actinomycetes Species That Synthesize Antibacterial Silver Nanoparticles Bizuye, Abebe; Gedamu, Lashitew; Bii, Christine; Gatebe, Erastus; Maina, Naomi Abebe Bizuye, Lashitew Gedamu, Christine Bii, Erastus Gatebe, and Naomi Maina, “Molecular-Based Identification of Actinomycetes Species That Synthesize Antibacterial Silver Nanoparticles,” International Journal of Microbiology, vol. 2020, Article ID 8816111, 17 pages, 2020. doi:10.1155/2020/8816111 http://dx.doi.org/10.1155/2020/8816111 Journal Article Downloaded from PRISM: https://prism.ucalgary.ca Research Article Molecular-Based Identification of Actinomycetes Species That Synthesize Antibacterial Silver Nanoparticles Abebe Bizuye ,1,2 Lashitew Gedamu,3 Christine Bii,4 Erastus Gatebe,5 and Naomi Maina 2,6 1Department of Medical Laboratory, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia 2Molecular Biology and Biotechnology, Pan African University Institute of Basic Sciences, Innovation and Technology, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya 3Department of Biological Sciences, University of Calgary, Calgary, Canada 4Centre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya 5Kenya Industrial Research Development and Innovation, Nairobi, Kenya 6Department of Biochemistry, College of Health Sciences, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya Correspondence should be addressed to Abebe Bizuye; [email protected] Received 18 August 2020; Revised 17 October 2020; Accepted 16 November 2020; Published 24 November 2020 Academic Editor: Diriba Muleta Copyright © 2020 Abebe Bizuye et al. +is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
    [Show full text]
  • Introduction (Pdf)
    Dictionary of Natural Products on CD-ROM This introduction screen gives access to (a) a general introduction to the scope and content of DNP on CD-ROM, followed by (b) an extensive review of the different types of natural product and the way in which they are organised and categorised in DNP. You may access the section of your choice by clicking on the appropriate line below, or you may scroll through the text forwards or backwards from any point. Introduction to the DNP database page 3 Data presentation and organisation 3 Derivatives and variants 3 Chemical names and synonyms 4 CAS Registry Numbers 6 Diagrams 7 Stereochemical conventions 7 Molecular formula and molecular weight 8 Source 9 Importance/use 9 Type of Compound 9 Physical Data 9 Hazard and toxicity information 10 Bibliographic References 11 Journal abbreviations 12 Entry under review 12 Description of Natural Product Structures 13 Aliphatic natural products 15 Semiochemicals 15 Lipids 22 Polyketides 29 Carbohydrates 35 Oxygen heterocycles 44 Simple aromatic natural products 45 Benzofuranoids 48 Benzopyranoids 49 1 Flavonoids page 51 Tannins 60 Lignans 64 Polycyclic aromatic natural products 68 Terpenoids 72 Monoterpenoids 73 Sesquiterpenoids 77 Diterpenoids 101 Sesterterpenoids 118 Triterpenoids 121 Tetraterpenoids 131 Miscellaneous terpenoids 133 Meroterpenoids 133 Steroids 135 The sterols 140 Aminoacids and peptides 148 Aminoacids 148 Peptides 150 β-Lactams 151 Glycopeptides 153 Alkaloids 154 Alkaloids derived from ornithine 154 Alkaloids derived from lysine 156 Alkaloids
    [Show full text]